| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
2 companies
Manchester Keith S is a Director at Roivant Sciences Ltd. with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 25 sells.
Estimated insider holdings value: $479.2M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 13, 2026 | ROIV Roivant Sciences Ltd. | Director | Sell | 1,225,784 | $26.64 | $32,658,518.16 | -1.6% | +11.5% | - | |
| Dec 17, 2025 | ROIV Roivant Sciences Ltd. | Director | Sell | 1,694,614 | $23.05 | $39,065,213.44 | -2.0% | +24.7% | - | |
| Nov 19, 2025 | ROIV Roivant Sciences Ltd. | Director | Sell | 1,300,000 | $20.23 | $26,304,500.00 | -1.7% | +33.2% | - | |
| Sep 25, 2024 | ROIV Roivant Sciences Ltd. | Director | Sell | 503,000 | $11.66 | $5,866,308.20 | -15.8% | +2.0% | +27.1% | |
| Aug 14, 2024 | ABUS Arbutus Biopharma Corp | Director | Sale+OE | 8,846 | $3.69 | $32,637.32 | -16.1% | -1.1% | -8.4% | |
| Sep 28, 2023 | ROIV Roivant Sciences Ltd. | Director | Sell | 6,896,144 | $11.55 | $79,650,463.20 | -8.2% | -7.7% | -8.5% | |
| Nov 10, 2022 | ROIV Roivant Sciences Ltd. | Director | Sell | 3,922,504 | $4.75 | $18,631,894.00 | -4.4% | +48.5% | +70.1% |